Organon & Co. - 10-Q Filing

Organon & Co. reports Q3 2026 financial results and updates on collaborative arrangements with Shanghai Henlius Biotech and Sebela Pharmaceutical.

SEC EDGAR ·

Tickers: $OGN

Read the full article at SEC EDGAR

More Regulatory news